ESPE Abstracts

Introduction: The increasing prevalence of pediatric obesity has led to a significant rise in the prescription of weight management medications. Between 2020 and 2035, the projected number of young people with overweight and obesity is expected to be 770 million, representing 39% of the global population, according to the World Obesity Atlas 2024. Glucagon-like peptide-1 (GLP-1) agonists, initially used for type 2 diabetes management, have shown promise in add...